secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0000896622-25-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup Q2 2025: adj. EPS $1.66 (+18% YoY), sales $966M (+6%), adj. EBITDA margin 22.6%
--------------------------------------------------------------------------------

- Reported sales $966M (+6% YoY); core sales +3%; net income $112M (+24%); adj. EPS $1.66 vs $1.41.
- Pharma core +3% (Injectables +9%, Active Material Science +11%); adj. EBITDA margin 35.4% (+130 bps).
- Closures core +7% (food & bev); Beauty core +1% (personal care up, fragrance subdued).
- Q3 adj. EPS guidance $1.53-$1.61; includes ~$0.06-$0.07 legal fees for pharma IP litigation.
- Returned $100M to shareholders ($70M buybacks, $30M dividends); quarterly dividend $0.45 payable Aug 14.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000026/0000896622-25-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000026/atr-20250731.htm
  HTML page:      https://secwatch.observer/filing/0000896622-25-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer